Patent · US Active

Stable glucagon peptide formulations

US9782344B2 · kind B2 · utility

4Cited by

6References

29Claims

0Family size

Assignee

ZP OPCO, INC. · US

Inventors

Mahmoud Ameri · Fremont, US
Peter Daddona · Menlo Park, US
Yi Ao · Palo Alto, US

Key dates

Filing date	Nov 2, 2015
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Dec 1, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2037/0061
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.